Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ExoJoints
- Development stage
- Preclinical
- Lead developer
- Bioscience Institute
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intraarticular
01
Overview
ExoJoints is an exosome-based therapy developed by the Bioscience Institute for orthopedic regeneration and joint repair. It consists of cell-free extracellular vesicles (exosomes) derived from human mesenchymal stem cells (MSCs). These exosomes carry a concentrated cargo of bioactive molecules, including lipids, messenger RNA, cytokines, and proteins, which act as intercellular messengers to promote tissue repair and modulate local immune responses. ExoJoints is administered via precise intra-articular or peri-articular injection to treat degenerative joint diseases, such as osteoarthritis, cartilage degeneration, and tendon or ligament injuries, by stimulating chondrocyte activity, promoting cartilage regeneration, and reducing joint inflammation and pain.
- Brand names
- ExoJoints
Beyond the preview
Go deeper on ExoJoints.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ExoJoints.